Nona aims to help global biopharmaceutical companies fast-track clinical trial initiation without compromising scientific rigor or quality standards
The new single-use commercial facility will be among India’s largest, featuring advanced technologies to produce high-quality biologics and specialty pharmaceuticals
Desai is currently serving the company as Group Finance Controller
The acquisition will follow the planned separation of Avidity’s early-stage precision cardiology programs into a new, independent company
This strategic collaboration represents the third clinical trial under Senhwa’s five-year NCI-sponsored cancer research program
CRISPR-based detection enables highly specific molecular recognition
The CRDMO segment contributed Rs. 452.7 crore, recording a robust 70.5 per cent YoY increase
The partnership aims to co-develop technologies set to revolutionize manufacturing of plasmid DNA (pDNA), a critical raw material for advanced medicines
The transaction, approved by both companies' boards of directors, is expected to close by the end of the first quarter of 2026
WuXi XDC's fully integrated ADC discovery service platform will significantly boost the speed and efficiency of LigaChem's ADC development programs
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
